isoniazid has been researched along with trifazid in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.92) | 18.7374 |
| 1990's | 20 (39.22) | 18.2507 |
| 2000's | 8 (15.69) | 29.6817 |
| 2010's | 21 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdi, A; Lema, E; Roscigno, G; Wolde, K | 1 |
| Brink, BA; Cowie, RL | 1 |
| Baumann, HR; Bohn, W; Brändli, O; Haegi, V; Villiger, B; Zäch, R | 1 |
| Allen, BW; Chan, SL; Ellard, DR; Ellard, GA; Girling, DJ; Ng, HK; Nunn, AJ; Tan, TH; Teo, SK | 1 |
| Chakorn, T; Pumprueg, U; Punnotok, J | 1 |
| de Villiers, CL; Macnab, MF | 1 |
| Bohmer, PD; Macnab, MF; Seager, JR | 1 |
| Ekmekçi, A; Sayli, A | 1 |
| Nightingale, SL | 1 |
| Alvarez, D; Chomón, B; Del Rio, MJ; San José, ME; Sarandeses, A; Valdés, L | 1 |
| Brändli, O; Dreher, D; Morger, D | 1 |
| Botha, FJ; Donald, PR; Mitchison, DA; Parkin, DP; Sirgel, FA; van de Wal, BW | 1 |
| McConville, JH | 1 |
| Berry, D; Scriven, JM | 1 |
| Chebbi, ML; Dakhlaoui, R; Drira, I; Jeguirim, MS; Souissi, R | 1 |
| Augustynowicz-Kopec, E; Grubek-Jaworska, H; Niemirowska-Mikulska, H; Safianowska, A; Stambrowska, H; Walkiewicz, R; Zwolska, Z | 1 |
| Iseman, MD | 1 |
| Chandrasekaran, V; Gurumurthy, P; Kumar, AK; Kumaraswami, V; Prabhakar, R; Ramachandran, G; Venkatesan, P; Vijayalakshmi, S; Vjayasekaran, V | 1 |
| Teo, SK | 1 |
| Lombard, CJ; Schoeman, JH; Tatley, M; Vundule, C; Zwarenstein, M | 1 |
| Barbaud, A; Fays, S; Martin, S; Schmutz, JL | 1 |
| Perng, RP; Su, WJ | 1 |
| Benito González, F; Benito González, JJ; Cordero Sánchez, M; Coscarón Blanco, E; del Cañizo Alvarez, A; Gómez González, JL; Santa Cruz Ruiz, S | 1 |
| Loots, DT; Mienie, LJ; Page, BJ; van Helden, PD; Wiid, IJ | 1 |
| Kibadi, K | 1 |
| Boldy, DA; Butt, MT; Oko, MO; Wray, D | 1 |
| Ho, YJ; Lee, CH; Lee, CL; Wei, YS | 1 |
| Abe, M; Kobashi, Y; Miyashita, N; Mouri, K; Obase, Y; Oka, M | 1 |
| Jablenska, L; Lo, S; Toma, A; Uddin, J | 1 |
| Mbassi Fouda, FL; Mulliez, P; Roy Saint-Georges, F | 1 |
| Huang, YH; Ko, JH; Lu, CF; Shih, YC; Yang, CH | 1 |
| Almeida, AC; Costa, JM; Galveia, JN; Guedes, ME | 1 |
| Bai, KJ; Chiang, CY; Hsu, YL; Lin, TP; Shih, HC; Yang, SL; Yen, MY; Yu, MC | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A | 1 |
| Hara, M; Hatta, T; Ohtani, M; Sawada, K; Segawa, H; Ueno, R | 1 |
| Chien, JY; Tsou, CC | 1 |
| Chen, TC; Chou, LT; Huang, CC; Lai, AB; Wang, JH | 1 |
| Akçay, A; Arslan, K; Dündar, M; İşcan, KM; Kanbur, M; Karabacak, M; Sarıca, ZS; Taşçıoğlu, N | 1 |
| Aarnoutse, R; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; ten Kate, MT; van Soolingen, D | 1 |
| Alawad, AAM; Khalifa, AFM | 1 |
| Mokos, ZB; Paštar, Z; Rezaković, S | 1 |
| Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
| Geiter, L; Mallikaarjun, S; Paccaly, A; Patil, S; Petersen, C; Shoaf, SE; Wells, C | 1 |
| Fu, L; Guo, Z; Li, P; Liu, S; Mu, X; Wang, B; Zhao, W; Zheng, M | 1 |
| Costa, DL; Dzutsev, A; Glickman, MS; Maiga, M; Mittereder, LR; Namasivayam, S; Sher, A; Thovarai, V; Trinchieri, G; Wipperman, MF; Yuan, W | 1 |
| Beer, N; Harris, RJ; Lipman, MC; Stagg, HR; van der Werf, MJ; Zenner, D | 1 |
| Balganesh, T; Bhavani, PK; Gomathy, SN; Guleria, R; Jawahar, SM; Kumar, H; Natrajan, M; Padmapriyadarsini, C; Ponnuraja, C; Singh, M; Swaminathan, S | 1 |
| Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
2 review(s) available for isoniazid and trifazid
| Article | Year |
|---|---|
Isolated tuberculous liver abscess in an immunocompetent adult patient: A case report and literature review.
Topics: Aged; Antitubercular Agents; Biopsy; Blood Chemical Analysis; Drug Combinations; Ethambutol; Humans; Isoniazid; Laparotomy; Liver; Liver Abscess; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Combinations; Humans; Isoniazid; Latent Tuberculosis; Network Meta-Analysis; Pyrazinamide; Rifampin | 2017 |
14 trial(s) available for isoniazid and trifazid
| Article | Year |
|---|---|
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hon
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Tablets; Tuberculosis, Pulmonary | 1990 |
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Thailand; Treatment Outcome; Tuberculosis, Pulmonary | 1995 |
Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis | 1994 |
[Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1993 |
Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Reference Values; Rifampin | 1998 |
Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Community Health Workers; Drug Combinations; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; South Africa; Tuberculosis | 2000 |
Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Rifampin; Sputum; Taiwan; Tuberculosis, Pulmonary | 2002 |
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Organophosphonates; Oxazines; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
Topics: Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Ethambutol; Female; Healthy Volunteers; Humans; Isoniazid; Male; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2016 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Metformin; Multicenter Studies as Topic; Mycobacterium tuberculosis; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2019 |
35 other study(ies) available for isoniazid and trifazid
| Article | Year |
|---|---|
Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1992 |
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
Topics: Acetylation; Adolescent; Adult; Biological Availability; Drug Combinations; Humans; Isoniazid; Middle Aged; Osmolar Concentration; Phenotype; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1986 |
Relapse rates in tuberculosis patients.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1995 |
Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment.
Topics: Adult; Antitubercular Agents; Cell Division; Chromosome Aberrations; Drug Combinations; Female; Humans; Isoniazid; Lymphocytes; Male; Middle Aged; Mitotic Index; Mutagens; Pyrazinamide; Rifampin; Sister Chromatid Exchange; Tuberculosis, Pulmonary | 1995 |
From the Food and Drug Administration.
Topics: Antitubercular Agents; Blood Donors; Drug Approval; Drug Combinations; Electromagnetic Phenomena; Equipment and Supplies; Equipment Failure; HIV Infections; HIV Seronegativity; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; United States; United States Food and Drug Administration; Wheelchairs | 1994 |
Determination of iron by the Ferrochem II: interference by tuberculostatics.
Topics: Antitubercular Agents; Drug Combinations; Electrochemistry; Humans; Iron; Isoniazid; Pyrazinamide; Rifampin; Spectrophotometry, Atomic | 1993 |
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 1996 |
Whither the roles of rifater and rifamate?
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Trimethoprim; Tuberculosis | 1996 |
Multiple small bowel perforations in a patient on treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Intestinal Perforation; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 1996 |
[Oral desensitization to antitubercular agents].
Topics: Administration, Oral; Adult; Antitubercular Agents; Desensitization, Immunologic; Drug Combinations; Female; Humans; Isoniazid; Pyrazinamide; Rifampin | 1997 |
Good news and not such good news.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1999 |
Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
Topics: Adult; Antitubercular Agents; Biological Availability; Cross-Over Studies; Drug Combinations; Humans; Isoniazid; Male; Pyrazinamide; Rifampin | 1999 |
New TB drug approved.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1995 |
[Pulmonary tuberculosis presenting as tubercular lupus].
Topics: Adolescent; Antitubercular Agents; Biopsy; Drug Combinations; Female; Humans; Isoniazid; Lupus Vulgaris; Luxembourg; Philippines; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2002 |
[Tuberculous otitis media. Report of 3 cases].
Topics: Adult; Aged; Amoxicillin; Antitubercular Agents; Cerebrospinal Fluid Otorrhea; Drug Combinations; Ear Diseases; Female; Humans; Isoniazid; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Otitis Media; Penicillins; Proteus Infections; Proteus mirabilis; Pyrazinamide; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tuberculosis | 2003 |
Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model.
Topics: Animals; Antioxidants; Antitubercular Agents; Carboxylic Acids; Death Domain Receptor Signaling Adaptor Proteins; Drug Combinations; Free Radicals; Guanine Nucleotide Exchange Factors; Hydroxybenzoates; Isoniazid; Melatonin; Oxidative Stress; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin | 2005 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |
Hoarseness due to Mycobacterium kansasii.
Topics: Antitubercular Agents; Drug Combinations; Hoarseness; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Vocal Cord Paralysis | 2009 |
Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
Topics: Aged; Antitubercular Agents; Arthroplasty, Replacement, Knee; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Taiwan; Tuberculosis, Osteoarticular | 2009 |
Rapid diagnosis of tuberculous pericarditis by ELISPOT assay.
Topics: Aged, 80 and over; Antitubercular Agents; Drug Combinations; Enzyme-Linked Immunospot Assay; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pericardial Effusion; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; T-Lymphocytes | 2010 |
Nasolacrimal tuberculosis: case report highlighting the need for imaging in identifying and managing it effectively.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus Diseases; Nasolacrimal Duct; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular | 2010 |
[Cutaneous reaction after pyrazinamide initiation].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Dysgeusia; Flushing; Histamine H1 Antagonists; Humans; Isoniazid; Loratadine; Male; Pruritus; Pyrazinamide; Recurrence; Rifampin; Tryptases; Tuberculosis, Pulmonary; Vasodilation | 2011 |
Acute tuberculosis cutis miliaris disseminata in a patient with systemic lupus erythematosus.
Topics: Acute Disease; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Pyrazinamide; Rifampin; Steroids; Tuberculosis, Cutaneous; Tuberculosis, Miliary | 2011 |
Tubercular serpiginous-like choroiditis.
Topics: Antitubercular Agents; Choroiditis; Drug Combinations; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Ocular; Vision Disorders | 2011 |
Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.
Topics: Adult; Aged; Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Taiwan; Tuberculosis; Young Adult | 2012 |
[A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
Topics: Abdominal Pain; Antitubercular Agents; Biomarkers; CA-125 Antigen; Diagnosis, Differential; Diarrhea; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Receptors, Interleukin-2; Renal Dialysis; Rifampin; Treatment Outcome | 2013 |
Olfactory disturbance related to pyrazinamide.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Male; Middle Aged; Olfaction Disorders; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
Genotoxic effects of some antituberculosis drugs and mixtures in rats.
Topics: Animals; Antitubercular Agents; DNA Damage; Drug Combinations; Ethambutol; Isoniazid; Kidney; Liver; Male; Pyrazinamide; Rats; Rifampin | 2015 |
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Isoniazid; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Stem Cells; Thioridazine; Tuberculosis | 2014 |
A Rare Cause of Retropharyngeal Abscess: Cervical Pott's Disease.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Cervical Vertebrae; Child; Diagnosis, Differential; Drug Combinations; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Neck; Pyrazinamide; Radiography; Retropharyngeal Abscess; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2015 |
Pyridoxine induced rosacea-like dermatitis.
Topics: Antitubercular Agents; Drug Combinations; Drug Eruptions; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Pyridoxine; Rifampin; Rosacea; Tuberculosis, Pulmonary; Vitamin B Complex | 2015 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Capreomycin; Drug Combinations; Drug Interactions; Humans; Isoniazid; Linezolid; Male; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Topics: Animals; Antitubercular Agents; Clostridiales; Drug Combinations; Dysbiosis; Gastrointestinal Microbiome; Intestines; Isoniazid; Mice; Mycobacterium tuberculosis; Porphyromonas; Pyrazinamide; Rifampin; RNA, Ribosomal, 16S; Tuberculosis, Pulmonary | 2017 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |